With considerable effort towards R&D, we have already assigned a target CAGR of 10-15% per year and an ambitious plan to develop 15-20 molecules for DMF filing. Our company collaborates... Read More
Author: Shobha Life Sciences
Vonoprazan Fumarate API is used mainly to cure gastroesophageal reflux disease and other forms of digestive disorders such as peptic ulcer disease, and zollinger-ellison syndrome. It is a proton pump... Read More